Ads
related to: warfarin poison for skunks treatment over the counter products
Search results
Results From The WOW.Com Content Network
Brodifacoum is a 4-hydroxycoumarin anticoagulant, with a similar mode of action to its historical predecessors dicoumarol and warfarin.However, due to very high potency and long duration of action (elimination half-life of 20 – 130 days), it is characterised as a "second-generation" or "superwarfarin" anticoagulant.
d-CON is an America brand of rodent control products, which is distributed and owned in the United States by the UK-based consumer goods company Reckitt. The brand includes traps and baits for use around the home for trapping and killing some rats and mice. As of 2015, bait products use first-generation vitamin K anticoagulants as poison.
Potentiates warfarin activity, leading to excessive anticoagulation and bleeding [3] [13] Dong quai female ginseng Angelica sinensis: May induce uterine contractions; contraindicated when pregnant or nursing [14] European Mistletoe: common mistletoe Viscum album: Toxic to cardio and central nervous systems, gastrointestinal bleeding [3] Ephedra ...
For premium support please call: 800-290-4726 more ways to reach us
The poison is effectively transferred through milk of mothers to nursing mammalian infants. Treatment: Vitamin K reverses the anticoagulant effect of rodenticides over a period of 24 to 48 hours from initiation of therapy. Caught early enough, Vitamin K can be rapidly administered by subcutaneous injection and followed up with by food-based ...
However, in the case of the second generation superwarfarins intended to kill warfarin-resistant rodents, the time of vitamin K administration may need to be prolonged to months, in order to combat the long residence time of the poison. [2] The vitamin K antagonists can cause birth defects . [3]
(Reuters) -High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder's Clinique, Target's Up & Up and Reckitt Benckiser-owned ...
See warfarin for a more detailed discovery history. Identified in 1940, dicoumarol became the prototype of the 4-hydroxycoumarin anticoagulant drug class. Dicoumarol itself, for a short time, was employed as a medicinal anticoagulant drug, but since the mid-1950s has been replaced by its simpler derivative warfarin, and other 4-hydroxycoumarin ...